Bioequivalency Study of 100 mg Cilostazol Tablets Under Fasting Conditions
NCT00602173
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class
Conditions
Intermittent Claudication
Interventions
DRUG:
Cilostazol
Sponsor
Roxane Laboratories